Page 47 - Read Online
P. 47
Almeida et al. Vessel Plus 2021;5:44 https://dx.doi.org/10.20517/2574-1209.2021.66 Page 11 of 14
Future collaborative research and interactions between basic and clinical research would be a good strategy
for the comprehensive understanding of the etiology and pathogenesis of AAV and ultimately for
improving the diagnosis, treatment, and prognosis of these patients.
DECLARATIONS
Authors’ contributions
Wrote and reviewed the biomarkers: Almeida S
Wrote and reviewed the pathogenesis: Neves MP
Wrote and reviewed the introduction: Da Silva Domingues V
All authors contributed for the final version of the paper.
Availability of data and materials
Not applicable.
Financial support and sponsorship
None.
Conflicts of interest
All authors declare that there are no conflicts of interest.
Ethical approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Copyright
© The Author(s) 2021.
REFERENCES
1. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus
aetiology? Br Med J (Clin Res Ed) 1982;285:606. DOI PubMed PMC
2. Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers 2020;6:71. DOI PubMed
3. Seeliger B, Sznajd J, Robson JC, et al. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
Rheumatology (Oxford) 2017;56:1154-61. DOI PubMed PMC
4. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
Arthritis Rheum 2013;65:1-11. DOI PubMed
5. Pearce FA, Craven A, Merkel PA, Luqmani RA, Watts RA. Global ethnic and geographic differences in the clinical presentations of
anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 2017;56:1962-9. DOI PubMed
6. Furuta S, Chaudhry AN, Arimura Y, et al. Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between
UK and Japanese Cohorts. J Rheumatol 2017;44:216-22. DOI PubMed
7. Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Position paper: Revised 2017 international consensus on testing of ANCAs in
granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017;13:683-92. DOI PubMed
8. Puéchal X, Pagnoux C, Perrodeau É, et al; French Vasculitis Study Group. Long-term outcomes among participants in the WEGENT
trial of remission-maintenance therapy for granulomatosis with polyangiitis (Wegener’s) or microscopic polyangiitis. Arthritis
Rheumatol 2016;68:690-701. DOI PubMed
9. Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
Ann Rheum Dis 2016;75:1583-94. DOI PubMed
10. Tanna A, Salama AD, Brookes P, Pusey CD. Familial granulomatosis with polyangiitis: three cases of this rare disorder in one
Indoasian family carrying an identical HLA DPB1 allele. BMJ Case Rep 2012;2012:bcr0120125502. DOI PubMed PMC
11. Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012;367:214-
23. DOI PubMed PMC
12. Kawasaki A, Hasebe N, Hidaka M, et al. Protective role of HLA-DRB1*13:02 against microscopic polyangiitis and MPO-ANCA-
positive vasculitides in a Japanese Population: a Case-Control Study. PLoS One 2016;11:e0154393. DOI PubMed PMC